ENDOTHELIOMATOSIS

ENDOTHELIOMATOSIS was reported 4 times

ENDOTHELIOMATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thyroid Hormone Synthesis Inhibitor [EPC] 2 0.0002
1 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
2 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
3 Opioid Agonist [EPC] 1 0.0000
4 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
5 Loop Diuretic [EPC] 1 0.0000
6 Proton Pump Inhibitor [EPC] 1 0.0000
7 Corticosteroid [EPC] 1 0.0000